The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
M | Musculo-skeletal system | |
2
|
M09 | Other drugs for disorders of the musculo-skeletal system | |
3
|
M09A | Other drugs for disorders of the musculo-skeletal system | |
4
|
M09AX | Other drugs for disorders of the musculo-skeletal system | |
5
|
M09AX15 |
| Active Ingredient |
|---|
|
Delandistrogene moxeparvovec is the recombinant gene therapy product that is comprised of a non-replicating, recombinant, adeno-associated virus (AAV) serotype rh74 (AAVrh74) capsid and a ssDNA expression cassette flanked by inverted terminal repeats (ITRs) derived from AAV2. The cassette contains: 1) an MHCK7 gene regulatory component comprising a creatine kinase 7 promoter and an α-myosin heavy chain enhancer, and 2) the DNA transgene encoding the engineered delandistrogene moxeparvovec micro-dystrophin protein. |
| Document | Type | Information Source | |
|---|---|---|---|
| ELEVIDYS Suspension for solution for infusion | MPI, US: SPL/PLR | FDA, National Drug Code (US) |